. Show Affiliations »
Abstract
Mesh： See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal, Humanized/therapeutic useBevacizumabBreast Neoplasms/drug therapyDisease-Free SurvivalDrug ApprovalFemaleHumansNeoplasm MetastasisUnited StatesUnited States Food and Drug Administration/standards
Substances： See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBevacizumab
Year: 2011 PMID： 21822220 DOI： 10.1038/nbt.1956
Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908